Empagliflozin Add on to Linagliptin Study in Japanese Patient With Type 2 Diabetes Mellitus
Clinical trial NCT02453555 · COMPLETED
Trial details
- NCT number
- NCT02453555
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-05-14
- Primary completion
- 2016-08-26
- Enrollment
- 275
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.